Bonus Presentations

A Comprehensive Review of AUVELITY: A Rapid-Acting Antidepressant That Modulates Both Glutamatergic and Monoaminergic Pathways

Speakers: John M. Hawkins, MD LFAPA & Paul Keck, MD

Sponsored by Axsome Therapeutics

This branded symposium will highlight the current unmet needs in MDD and present a treatment option with rapid symptom improvement for adult patients with MDD.

Empowering Treatment Choice With SPRAVATO®

Speakers: Stephen Givens, PhD & Jay Fawver, MD

Sponsored by Johnson & Johnson Innovative Medicine

Empowering Treatment Choice With SPRAVATO®” is an educational program focusing on care options for adult patients with treatment-resistant depression (TRD).

Tardive Dyskinesia is Personal: Go Beyond the Data with a Real Patient Story

Speakers: Rebecca Roma, MD & Patient Ambassadors

Sponsored by Neurocrine Biosciences

This program will communicate the burden and impacts of tardive dyskinesia; review a patient’s experience with tardive dyskinesia and the impacts it has had on their mental and physical well-being; explore a partner’s perspective on supporting someone with tardive dyskinesia; and discuss an FDA-approved treatment for adults with tardive dyskinesia, with detailed pharmacology discussion.

UZEDY: Discover the Features of a Different Kind of LAI

Speaker: Henry Nasrallah, MD

Sponsored by Teva Pharmaceuticals

This presentation reviews the importance of relapse prevention and explores the possible role of LAIs, such as UZEDY, in patients with schizophrenia.

Discover COBENFY, A First-in-Class Treatment for Adults Living with Schizophrenia

Speaker: Henry Nasrallah, MD

Sponsored by Bristol Myers Squibb

Exploring the Role of an Atypical Antipsychotic in Common Psychiatric Disorders

Speaker: Leslie Citrome, MD, MPH

Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck

You are invited to explore an atypical antipsychotic proven effective in treating two of the most prevalent psychiatric conditions.

An Established Treatment Option for Managing Bipolar I Disorder or Schizophrenia

Speaker: Rebecca Roma, MD

Sponsored by Alkermes, Inc.

This promotional program will provide an overview of the clinical data and information for use in clinical practice for a treatment option for adult patients living with bipolar l disorder or schizophrenia.